Hybrid Biological Cell Separations Technology for Lab-On-Chip Medical Devices
October 10, 2017 | Rochester Institute of TechnologyEstimated reading time: 2 minutes

Research being done at Rochester Institute of Technology to refine lab-on-chip devices—highly sophisticated laboratories on microchips—will provide more detailed and timely information to detect diseases such as cancer.
Blanca Lapizco-Encinas, a faculty-researcher in RIT’s Kate Gleason College of Engineering, is improving the process of separating biological cells and biomolecules using chromatography principles, a well-established technique for separating proteins, combined with a newer technique called dielectrophoresis, a process that uses electrical current to separate biomolecules.
In biomedical analysis, clinicians may have to analyze complex blood samples consisting of cells, proteins and other micron-sized particles, in an effort to separate healthy and diseased cells. Improved microfluidic techniques with the potential to separate cells found in bio-fluids, are useful in settings where rapid results are essential such as testing for food and water safety or clinical analysis of disease.
“You put into a device a sample with six or seven different types of particles and you can separate them, in some cases in less than two minutes, just by applying electric fields,” Lapizco-Encinas explained. “For lab-on-a-chip devices, you want results in minutes, because that is what is attractive about these portable and inexpensive devices—you can get a response right away.”
Lapizco-Encinas is building micro-channels into lab-on-chip devices that will have a dense array of insulating structures to emulate the stationary phase found in chromatographic systems. The new arrays have distinct columns where particles will be retained. Lab-on-chip devices are often made of glass or a silicon base where bio-fluids stream through etched channels. Devices also have complex sensors and electronics embedded, and the combined technologies will advance screening and laboratory analysis applications through a new technique she is calling dielectrophoresis chromatography.
“In chromatography, for example, particles enter a chromatographic column, and different particles are retained in different degrees. Particles that have a lower retention get eluted, or separated, from the column earlier. And particles that have a stronger retention get eluted from the column later, thus enabling a separation,” said Lapizco-Encinas, an associate professor of biomedical engineering who leads the Microscale BioSeparations Laboratory in RIT’s Kate Gleason College of Engineering. She was recently awarded $299, 611 from the National Science Foundation (NSF) for the hybrid microfluidics technique titled, “Development of dielectrophoresis chromatography employing asymmetric insulating structures and electric fields.”
The new research, utilizing electroosmotic flow—the motion of liquid in chemical separations—is expected to drive particles across the microchannel. This process of electroosmotic flow offers the potential for the biomolecules to be manipulated in real-time, allowing for dynamic separation schemes. This work expands Lapizco-Encinas’ previous research that focused on the development of multi-channel devices where fluid samples are assessed after being exposed to electrical currents that cause the bio-particles to separate for more efficient analysis. Through past research, she and her team advanced device system designs and determined an optimal threshold of electrical fields applied to adequately manipulate the fluids and ensure that live cells are not damaged. Adding chromatographic principles to this foundational work is underway.
“We have some preliminary designs; we will move forward with the research in two directions. We do significant mathematical modeling that allows us to design a system and then we do the experimental testing. My lab does both. We have preliminary designs we are currently testing, and those designs and experiments help us to improve the model and move forward to the next generation.”
Testimonial
"In a year when every marketing dollar mattered, I chose to keep I-Connect007 in our 2025 plan. Their commitment to high-quality, insightful content aligns with Koh Young’s values and helps readers navigate a changing industry. "
Brent Fischthal - Koh YoungSuggested Items
PC Graphics Add-in Board Shipments Up 27% QoQ in 2Q25
09/03/2025 | Jon Peddie ResearchAccording to a new research report from the analyst firm Jon Peddie Research, the growth of the global PC-based graphics add-in board market reached 11.6 million units in Q2'25 and desktop PC CPUs shipments increased to 21.7 million units.
PC GPU Shipments Up 8.4% in 2Q25 on Pre-Tariff Demand
09/02/2025 | Jon Peddie ResearchJon Peddie Research reports the growth of the global PC-based graphics processor unit (GPU) market reached 74.7 million units in Q2'25, and PC CPU shipments increased to 66.9 million units.
20 Years of Center Nanoelectronic Technologies (CNT) – Backbone of German Semiconductor Research Celebrates Anniversary
08/14/2025 | Fraunhofer IPMSThe Center Nanoelectronic Technologies (CNT) of the Fraunhofer Institute for Photonic Microsystems (IPMS) is celebrating its 20th anniversary this year. Since its founding in 2005, it has developed into a pillar of applied semiconductor research in Germany and Europe. With its unique research cleanroom and equipment adhering to the 300-mm wafer industry standard, CNT is unparalleled in Germany and serves as a central innovation driver for the microelectronics industry.
Q2 Client CPU Shipments Increased 8% from Last Quarter, Up 13% YoY
08/13/2025 | Jon Peddie ResearchJon Peddie Research reports that the global client CPU market expanded for two quarters in a row, and in Q2’25, it showed unseasonal growth of 7.9% from last quarter, while server CPU shipments increased 22% year over year.
FuriosaAI Closes $125M Investment Round to Scale Production of Next-Gen AI Inference Chip
07/31/2025 | BUSINESS WIREFuriosaAI, a semiconductor company building a new foundation for AI compute, today announced it has completed a $125 million Series C bridge funding round. The investment continues a period of significant momentum for Furiosa as global demand for high-performance, efficient AI infrastructure soars.